levoleucovorin and Epilepsies--Partial

levoleucovorin has been researched along with Epilepsies--Partial* in 2 studies

Reviews

1 review(s) available for levoleucovorin and Epilepsies--Partial

Article	Year
Anticonvulsants, folic acid, and epilepsy. Lancet (London, England), 1973, Jun-16, Volume: 1, Issue:7816 Topics: Anemia, Macrocytic; Animals; Anticonvulsants; Blood-Brain Barrier; Chemical Phenomena; Chemistry; Epilepsies, Partial; Epilepsy; Folic Acid; Humans; Leucovorin; Mice; Phenobarbital; Phenytoin; Primidone; Rabbits; Rats; Seizures	1973

Other Studies

1 other study(ies) available for levoleucovorin and Epilepsies--Partial

Article	Year
Atypical Presentation of a Progressive and Treatable Encephalopathy in an Older Child With Gelastic and Dacrystic Seizures. Seminars in pediatric neurology, 2018, Volume: 26 We discuss an unusual case of a teenage boy who presented with waxing and waning cognitive decline and gelastic-dacrystic seizures, evolving later into a rapidly progressive encephalopathy with status epilepticus. Extensive genetic and metabolic testing did not lead to a specific diagnosis. Cerebrospinal fluid studies performed during admission to the intensive care unit provided the information needed to establish a diagnosis. After implementation of specific treatment, his seizures stopped and his background electroencephalogram returned to normal. He has remained largely seizure-free experiencing a significant cognitive recovery. This case illustrates the importance of performing cerebrospinal fluid analysis in patient with refractory seizures and cognitive decline of unknown etiology. Topics: Adolescent; Anticonvulsants; Brain; Diagnosis, Differential; Disease Progression; Epilepsies, Partial; Humans; Leucovorin; Male; Pyridoxine; Status Epilepticus	2018

Article

Year

Atypical Presentation of a Progressive and Treatable Encephalopathy in an Older Child With Gelastic and Dacrystic Seizures.

Seminars in pediatric neurology, 2018, Volume: 26

We discuss an unusual case of a teenage boy who presented with waxing and waning cognitive decline and gelastic-dacrystic seizures, evolving later into a rapidly progressive encephalopathy with status epilepticus. Extensive genetic and metabolic testing did not lead to a specific diagnosis. Cerebrospinal fluid studies performed during admission to the intensive care unit provided the information needed to establish a diagnosis. After implementation of specific treatment, his seizures stopped and his background electroencephalogram returned to normal. He has remained largely seizure-free experiencing a significant cognitive recovery. This case illustrates the importance of performing cerebrospinal fluid analysis in patient with refractory seizures and cognitive decline of unknown etiology.

Topics: Adolescent; Anticonvulsants; Brain; Diagnosis, Differential; Disease Progression; Epilepsies, Partial; Humans; Leucovorin; Male; Pyridoxine; Status Epilepticus

2018